Therapy News and Research

RSS

Fecal microbiota transplantation emerges as a promising approach to H. pylori eradication

FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient's gastrointestinal tract.

10 Apr 2025

Understanding key risk factors behind shoulder injuries in athletes and aging adults

Shoulders are, in many ways, a marvel. One shoulder has four separate joints, packed with muscles, that allow us to move our arm in eight different major ways, giving us the most degrees of freedom of any joint in the body.

10 Apr 2025

Can psychedelics break compulsive eating habits in obesity?

A review by Oxford researchers explores how psychedelics like psilocybin and LSD may help disrupt compulsive eating behaviors in subsets of obese individuals. The paper outlines proposed neurobiological, epigenetic, and gut-brain mechanisms while emphasizing the need for human trials.

10 Apr 2025

WHO releases first global guidelines to improve meningitis care

The World Health Organization (WHO) has today published its first-ever global guidelines for meningitis diagnosis, treatment and care, aiming to speed up detection, ensure timely treatment, and improve long-term care for those affected.

10 Apr 2025

Mindfulness and cognitive behavioral therapies offer lasting relief for chronic low back pain

Researchers compare the long-term effectiveness of mindfulness and CBT among adults with opioid-treated chronic low back pain.

10 Apr 2025

Study overcomes chemotherapy limitations with lipid nanoparticles

Announcing a new article publication for the BIO Integration journal. Lipid-based Nanoparticles (LBNPs) have emerged as a transformative approach in cancer treatment, offering innovative drug delivery solutions that enhance therapeutic efficacy while minimizing adverse effects.

10 Apr 2025

Exophiala pneumonia identified in immunocompetent woman with lung disease

Exophiala, a genus of saprotrophic black fungi commonly found in the environment, is typically associated with cutaneous infections in immunocompromised hosts and rarely manifests as pneumonia.

9 Apr 2025

Sylvester Cancer Center launches clinical trial for patients with high-grade neuroendocrine tumors

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

9 Apr 2025

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

9 Apr 2025

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal lean muscle mass loss as they lost weight across 6 months of treatment.

9 Apr 2025

UCLA study identifies key protein driving kidney scarring

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a potential precision medicine approach to prevent chronic kidney disease progression.

9 Apr 2025

Scientists stop long-COVID symptoms in mice using a new antiviral compound

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical efficacy in reducing both acute and long COVID symptoms in mice.

9 Apr 2025

New STITCHR tool offers a promising step forward for gene therapy

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations.

9 Apr 2025

ETH Zurich researchers identify redundancies between the genes involved in DNA repair

Researchers aThe DNA of human cells consists of a sequence of about 3.1 billion building blocks. Cells go to great lengths to maintain the integrity of this vast store of information.t ETH Zurich have unraveled the complex network that cells use to repair their genetic material.

9 Apr 2025

Advancing Adherent Cell Assays with SemaCyte® Technology

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance scalability and efficiency in drug discovery.

From Semarion 9 Apr 2025

Dynamic BH3 profiling offers personalized lung cancer therapies

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

9 Apr 2025

Tiny facial movements could help better understand social communication in autistic individuals

A study led by Rutgers University-New Brunswick researchers suggests that tiny facial movements – too slight for the human eye to notice – could help scientists better understand social communication in people with autism.

9 Apr 2025

Can nature-based therapies heal people and the planet? Study investigates holistic solutions

Researchers at Swansea University have developed a protocol for a scoping review to explore how nature-based interventions influence individual, collective, and planetary well-being.

9 Apr 2025

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing secondary progressive multiple sclerosis (SPMS).

8 Apr 2025

New drug compound prevents long COVID symptoms in mice

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.

8 Apr 2025

Therapy News and Research

Fecal microbiota transplantation emerges as a promising approach to H. pylori eradication

Understanding key risk factors behind shoulder injuries in athletes and aging adults

Can psychedelics break compulsive eating habits in obesity?

WHO releases first global guidelines to improve meningitis care

Mindfulness and cognitive behavioral therapies offer lasting relief for chronic low back pain

Study overcomes chemotherapy limitations with lipid nanoparticles

Exophiala pneumonia identified in immunocompetent woman with lung disease

Sylvester Cancer Center launches clinical trial for patients with high-grade neuroendocrine tumors

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

UCLA study identifies key protein driving kidney scarring

Scientists stop long-COVID symptoms in mice using a new antiviral compound

New STITCHR tool offers a promising step forward for gene therapy

ETH Zurich researchers identify redundancies between the genes involved in DNA repair

Advancing Adherent Cell Assays with SemaCyte® Technology

Dynamic BH3 profiling offers personalized lung cancer therapies

Tiny facial movements could help better understand social communication in autistic individuals

Can nature-based therapies heal people and the planet? Study investigates holistic solutions

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

New drug compound prevents long COVID symptoms in mice

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News